Influence of race and sex on lipoprotein-associated phospholipase A2 levels: observations from the Dallas Heart Study
- PMID: 18061193
- PMCID: PMC2495009
- DOI: 10.1016/j.atherosclerosis.2007.10.010
Influence of race and sex on lipoprotein-associated phospholipase A2 levels: observations from the Dallas Heart Study
Abstract
Aims: Most lipoprotein-associated phospholipase A2 (Lp-PLA2) studies included mainly white men. We sought to determine whether Lp-PLA2 levels differ according to race and sex.
Methods: Lp-PLA2 mass and activity were measured in 3332 subjects age 30-65 participating in the Dallas Heart Study, a multiethnic, population-based, probability sample. Lp-PLA2 levels were compared between different race and sex groups.
Results: Mean age was 45+/-9 years and 44% were men; 30% were white, 17% hispanic, and 53% black. Mean Lp-PLA2 activity and mass were 146+/-40 nmol/min/mL and 191+/-60 ng/mL, respectively. Lp-PLA2 activity was lower in women compared with men (134+/-35 vs. 161+/-40, p=0.001) and was lowest in black (136+/-38), intermediate in hispanic (151+/-36), and highest in white subjects (161+/-39) (trend p=0.0001). In multivariable linear regression models, after adjusting for age, body mass index (BMI), smoking, total, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol, triglycerides and high sensitivity C-reactive protein (hsCRP), Lp-PLA2 activity was 19 nmol/min/mL higher in men vs. women (p<0.001); compared with black subjects, adjusted Lp-PLA2 activity was 11 and 20 nmol/min/mL higher in white and hispanic subjects, respectively (both p<0.001). Similar race and sex differences were observed for Lp-PLA2 mass.
Conclusion: Race and sex independently influence Lp-PLA2 activity and mass. Thresholds to define Lp-PLA2 elevation may need to be sex and race specific.
Figures




Similar articles
-
Association of lipoprotein-associated phospholipase A2 with coronary calcification among American and Japanese men.J Epidemiol. 2007 Nov;17(6):179-85. doi: 10.2188/jea.17.179. J Epidemiol. 2007. PMID: 18094516 Free PMC article.
-
Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) in acute coronary syndrome: relationship with low-density lipoprotein cholesterol.Can J Cardiol. 2013 Dec;29(12):1679-86. doi: 10.1016/j.cjca.2013.09.026. Epub 2013 Oct 2. Can J Cardiol. 2013. PMID: 24267807
-
Relationship between plasma phospholipase A2 concentrations and lipoprotein subfractions in patients with stable coronary artery disease.Clin Chim Acta. 2015 Jun 15;446:195-200. doi: 10.1016/j.cca.2015.04.032. Epub 2015 Apr 28. Clin Chim Acta. 2015. PMID: 25934512
-
Pathophysiological role and clinical significance of lipoprotein-associated phospholipase A₂ (Lp-PLA₂) bound to LDL and HDL.Curr Pharm Des. 2014;20(40):6256-69. doi: 10.2174/1381612820666140622200916. Curr Pharm Des. 2014. PMID: 24953389 Review.
-
The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma.Biochim Biophys Acta. 2009 May;1791(5):327-38. doi: 10.1016/j.bbalip.2009.02.015. Biochim Biophys Acta. 2009. PMID: 19272461 Review.
Cited by
-
Dietary, lifestyle, and clinical predictors of lipoprotein-associated phospholipase A2 activity in individuals without coronary artery disease.Am J Clin Nutr. 2010 Mar;91(3):786-93. doi: 10.3945/ajcn.2009.28870. Epub 2010 Jan 27. Am J Clin Nutr. 2010. PMID: 20107195 Free PMC article.
-
The association between dietary quality scores with C-reactive protein and novel biomarkers of inflammation platelet-activating factor and lipoprotein-associated phospholipase A2: a cross-sectional study.Nutr Metab (Lond). 2023 Sep 12;20(1):38. doi: 10.1186/s12986-023-00756-x. Nutr Metab (Lond). 2023. PMID: 37700354 Free PMC article.
-
Sex differences in the relationship between C-reactive protein and body fat.J Clin Endocrinol Metab. 2009 Sep;94(9):3251-8. doi: 10.1210/jc.2008-2406. Epub 2009 Jun 30. J Clin Endocrinol Metab. 2009. PMID: 19567538 Free PMC article.
-
Sex differences in the association of phospholipids with components of the metabolic syndrome in young adults.Biol Sex Differ. 2017 Mar 28;8:10. doi: 10.1186/s13293-017-0131-0. eCollection 2017. Biol Sex Differ. 2017. PMID: 28360990 Free PMC article.
-
Association of lipoprotein-associated phospholipase A2 with coronary artery disease in African-Americans and Caucasians.J Clin Endocrinol Metab. 2010 May;95(5):2376-83. doi: 10.1210/jc.2009-2498. Epub 2010 Mar 1. J Clin Endocrinol Metab. 2010. PMID: 20194707 Free PMC article.
References
-
- Garza CA, Montori VM, McConnell JP, Somers VK, Kullo IJ, Lopez-Jimenez F. Association between lipoprotein-associated phospholipase A2 and cardiovascular disease: a systematic review. Mayo Clin Proc. 2007;82:159–65. - PubMed
-
- Ballantyne CM, Hoogeveen RC, Bang H, et al. Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study. Circulation. 2004;109:837–42. - PubMed
-
- Koenig W, Khuseyinova N, Lowel H, Trischler G, Meisinger C. Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: results from the 14-year follow-up of a large cohort from southern Germany. Circulation. 2004;110:1903–8. - PubMed
-
- Oei HH, van der Meer IM, Hofman A, et al. Lipoprotein-associated phospholipase A2 activity is associated with risk of coronary heart disease and ischemic stroke: the Rotterdam Study. Circulation. 2005;111:570–5. - PubMed
-
- Brilakis ES, McConnell JP, Lennon RJ, Elesber AA, Meyer JG, Berger PB. Association of lipoprotein-associated phospholipase A2 levels with coronary artery disease risk factors, angiographic coronary artery disease, and major adverse events at follow-up. Eur Heart J. 2005;26:137–44. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials